Literature DB >> 10330536

[Epidemiological study of chronic obstructive pulmonary disease in Spain (IBERPOC): prevalence of chronic respiratory symptoms and airflow limitation].

V Sobradillo1, M Miravitlles, C A Jiménez, R Gabriel, J L Viejo, J F Masa, L Fernández-Fau, C Villasante.   

Abstract

The prevalence of chronic respiratory symptoms and chronic airflow limitation (CAFL) was determined in a multicentric epidemiological study carried out in seven different areas of Spain. Based on a target population of 236,412 persons, a random census sample of 4,035 individuals between 40 and 69 years of age was chosen. Subjects answered several questionnaires and performed spirometric tests followed by a bronchodilation test if bronchial obstruction was detected. Respiratory symptoms were reported by 48% of the population (95% CI: 46.4-49.5%) with greater frequency of symptoms among men than women (55.2% versus 41%, p < 0.001). The following levels of prevalence of chronic symptoms were found: cough, 13.5% (95% CI: 12.5-14.6%); expectoration, 10.7% (95% CI: 9.7-11.6%); dyspnea after one flight of stairs, 10.4% (95% CI: 9.5-11.4%); and wheezing, 40.2% (95% CI: 38.7-41.7%). The prevalence of chronic bronchitis (CB) was 4.8% (95% CI: 4.1-5.4%) and was more frequent among men than among women (8.3% and 1.4%, respectively; p < 0.001). Asthma had been diagnosed previously in 4.9% (95% CI: 4.2-5.5%), more often in women than in men (5.8% and 3.8%, respectively; p < 0.003). CAFL was found in 10.6% (95% CI: 9.6-11.5%), 15.8% in men and 5.5% in women (p < 0.001). All respiratory symptoms except asthma were more frequent among smokers than among ex-smokers, and in turn were more common among ex-smokers than non-smokers. The frequency of symptoms increased in accordance with accumulated smoking. The prevalence of CB and CAFL was vastly different from one region to another. Multivariate analysis showed that factors associated independently with the appearance of CB were smoking, age over 60 years, male sex and having worked in industry. In conclusion, respiratory symptoms, including CB and CAFL, are common in the Spanish population. Smoking and amount of smoking are directly related to the frequency of such symptoms. Substantial differences were found in the prevalence of CB and CAFL among the regions where the study was performed.

Entities:  

Mesh:

Year:  1999        PMID: 10330536     DOI: 10.1016/s0300-2896(15)30272-6

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  23 in total

1.  Chronic Bronchitis: Where Are We Now?

Authors:  Yaniv Dotan; Jennifer Y So; Victor Kim
Journal:  Chronic Obstr Pulm Dis       Date:  2019-04-09

Review 2.  Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema.

Authors:  Barbara A Forey; Alison J Thornton; Peter N Lee
Journal:  BMC Pulm Med       Date:  2011-06-14       Impact factor: 3.317

3.  The St. George's Respiratory Questionnaire Definition of Chronic Bronchitis May Be a Better Predictor of COPD Exacerbations Compared With the Classic Definition.

Authors:  Victor Kim; Huaqing Zhao; Elizabeth Regan; MeiLan K Han; Barry J Make; James D Crapo; Paul W Jones; Jeffrey L Curtis; Edwin K Silverman; Gerard J Criner
Journal:  Chest       Date:  2019-05-15       Impact factor: 9.410

4.  Comparison between an alternative and the classic definition of chronic bronchitis in COPDGene.

Authors:  Victor Kim; James Crapo; Huaqing Zhao; Paul W Jones; Edwin K Silverman; Alejandro Comellas; Barry J Make; Gerard J Criner
Journal:  Ann Am Thorac Soc       Date:  2015-03

Review 5.  The chronic bronchitis phenotype in chronic obstructive pulmonary disease: features and implications.

Authors:  Victor Kim; Gerard J Criner
Journal:  Curr Opin Pulm Med       Date:  2015-03       Impact factor: 3.155

6.  Evaluation of a combined strategy directed towards health-care professionals and patients with chronic obstructive pulmonary disease (COPD): information and health education feedback for improving clinical monitoring and quality-of-life.

Authors:  Carles Valero; Mònica Monteagudo; Maria Llagostera; Xavier Bayona; Sílvia Granollers; Mateo Acedo; Juan J Ferro; Lluïsa Rodríguez-Latre; Jesús Almeda; Laura Muñoz
Journal:  BMC Public Health       Date:  2009-12-01       Impact factor: 3.295

Review 7.  Chronic bronchitis and chronic obstructive pulmonary disease.

Authors:  Victor Kim; Gerard J Criner
Journal:  Am J Respir Crit Care Med       Date:  2012-11-29       Impact factor: 21.405

8.  Respiratory symptoms in older people and their association with mortality.

Authors:  J Hewitt; L Smeeth; C J Bulpitt; A J Tulloch; A E Fletcher
Journal:  Thorax       Date:  2005-04       Impact factor: 9.139

9.  Is it possible to diagnose the therapeutic adherence of patients with COPD in clinical practice? A cohort study.

Authors:  Pilar Barnestein-Fonseca; José Leiva-Fernández; Francisca Vidal-España; Antonio García-Ruiz; Daniel Prados-Torres; Francisca Leiva-Fernández
Journal:  BMC Pulm Med       Date:  2011-01-24       Impact factor: 3.317

10.  Assessment of a primary and tertiary care integrated management model for chronic obstructive pulmonary disease.

Authors:  Ignasi Bolíbar; Vicente Plaza; Mariantònia Llauger; Ester Amado; Pedro A Antón; Ana Espinosa; Leandra Domínguez; Mar Fraga; Montserrat Freixas; Josep A de la Fuente; Iskra Liguerre; Casimira Medrano; Meritxell Peiro; Mariantònia Pou; Joaquin Sanchis; Ingrid Solanes; Carles Valero; Pepi Valverde
Journal:  BMC Public Health       Date:  2009-02-24       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.